| Title: |
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID) |
| Authors: |
Agafina, AlinaAff1; Aguiar, Valeria CristinaAff2; Rossovskaya, MariaAff3; Fartoukh, Muriel SarahAff4; Hajjar, Ludhmila AbrahaoAff5; Thiéry, GuillaumeAff6; Timsit, Jean-FrançoisAff7; Gordeev, IvanAff8; Protsenko, DenisAff9; Carbone, JavierAff10; Pellegrini, RitaAff11; Stadnik, Claudio Marcel BerdunAff12; Avdeev, SergeyAff13; Ferrer, MiquelAff14; Heinz, Corina CAff15; Häder, ThomasAff15; Langohr, PatrickAff15; Bobenhausen, IrisAff15; Schüttrumpf, JörgAff15, Aff16; Staus, AlexanderAff15; Ruehle, MarkusAff15; Weissmüller, SabrinaAff15; Wartenburg-Demand, AndreaAff15; Torres, AntoniAff17, IDs4000102402008x_cor24 |
| Source: |
European Journal of Medical Research. 29(1) |
| Database: |
Springer Nature Journals |